Trial Profile

An open label study of high concentration inhaled nitric oxide (NO) using the LungFit system for COVID-19 patients in The USA

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 11 Aug 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nitric oxide (Primary)
Indications COVID 2019 infections; Respiratory tract disorders
Focus Therapeutic Use
Sponsors Beyond Air

Most Recent Events

06 Aug 2020 According to a Beyond Air media release, the company expects to provide updates from this study over the coming months.
15 Jun 2020 According to a Beyond Air media release, first patient has been enrolled in the study. The patient was enrolled at the Baptist Health Center for Clinical Research in Little Rock, Arkansas.
15 Jun 2020 Status changed from planning to recruiting, according to a Beyond Air media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com